http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-862194-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e89320eac95bdc00163fb579afcd668 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-72 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-72 |
| filingDate | 1958-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1961-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-862194-A |
| titleOfInvention | 5-substituted hydrantoins and their preparation |
| abstract | The invention comprises 5-(2,4-dihalophenyl) hydantoins and their salts (e.g. alkali and alkaline-earth metal, ammonium and amine salts) and pharmaceutical preparations containing them (see Group VI). The substituted hydantoins can be made by reacting an appropriate 2,4-dihalobenzaldehyde with an alkali metal cyanide and ammonium carbonate.ALSO:Pharmaceutical compositions comprise a 5-(2,4-ditalophenyl) hydantoin, or a salt thereof, and a pharmaceutical carrier therefor. For parenteral injection, the carrier may be sterile water; for oral administration, the dosage may be in the form of a capsule, a powder adapted for suspension in liquid media, or a tablet. They have anti-epileptic activity; and the active ingredients may also be used as plant growth regulants. Specified salts are those with alkali metals (e.g. sodium, potassium or lithium) and alkaline-earth metals (e.g. magnesium), ammonium salts, and salts of organic bases (e.g. ethanolamine and ethylenediamine). |
| priorityDate | 1958-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.